SLA's last annual report was for financial year 2015. http://www.solagran.com/annual-reports.html In that financial year no payments in cash were made to directors, and no share or options handed out.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025